The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward human-biology-based testing methods for monoclonal antibody programs. The ...
Millions of people in the United States have type 2 diabetes and/or obesity. Many of the drugs that treat these often cause people to lose muscle mass. Muscle mass loss can cause a loss of strength ...
One of the persistent themes we confront at SBM is the evolving double-standard in clinical medicine. On the one hand, in ...
Prescription drug costs continue to climb and are a growing burden on patients, employers and taxpayers. Unlike other purchases, neither prescribers nor patients typically know the cost of a drug when ...
The study highlights that after stopping GLP-1 medications, many patients resume treatment or try alternatives, influencing weight management strategies.
CHARLESTON, S.C. (WCSC) - As the new year sparks a wave of weight loss resolutions and millions turn to weight loss medications, rising costs and the growing popularity of compounded alternatives have ...
Sedona inpatient program emphasizes gradual tapering, seizure-risk awareness, and holistic strategies to address ...